153 related articles for article (PubMed ID: 8463169)
1. A membrane-bound precursor beta-lactamase in strains of Moraxella catarrhalis and Moraxella nonliquefaciens that produce periplasmic BRO-1 and BRO-2 beta-lactamases.
Steingrube VA; Wallace RJ; Beaulieu D
J Antimicrob Chemother; 1993 Feb; 31(2):237-44. PubMed ID: 8463169
[TBL] [Abstract][Full Text] [Related]
2. Characterization of cell-bound papain-soluble beta-lactamases in BRO-1 and BRO-2 producing strains of Moraxella (Branhamella) catarrhalis and Moraxella nonliquefaciens.
Eliasson I; Kamme C; Vang M; Waley SG
Eur J Clin Microbiol Infect Dis; 1992 Apr; 11(4):313-21. PubMed ID: 1396750
[TBL] [Abstract][Full Text] [Related]
3. BRO beta-lactamases of Branhamella catarrhalis and Moraxella subgenus Moraxella, including evidence for chromosomal beta-lactamase transfer by conjugation in B. catarrhalis, M. nonliquefaciens, and M. lacunata.
Wallace RJ; Steingrube VA; Nash DR; Hollis DG; Flanagan C; Brown BA; Labidi A; Weaver RE
Antimicrob Agents Chemother; 1989 Nov; 33(11):1845-54. PubMed ID: 2514622
[TBL] [Abstract][Full Text] [Related]
4. Characterization of BRO enzymes and beta-lactamase transfer of Moraxella (Branhamella) catarrhalis isolated in Japan.
Ikeda F; Yokota Y; Mine Y; Yamada T
Chemotherapy; 1993; 39(2):88-95. PubMed ID: 8458251
[TBL] [Abstract][Full Text] [Related]
5. [beta-Lactamases of Branhamella catarrhalis and their phenotypic implications].
Chaïbi EB; Mugnier P; Kitzis MD; Goldstein FW; Acar JF
Res Microbiol; 1995; 146(9):761-71. PubMed ID: 8584798
[TBL] [Abstract][Full Text] [Related]
6. The beta-lactamases of Moraxella (Branhamella) catarrhalis isolated from Danish children.
Ejlertsen T; Skov R
APMIS; 1996; 104(7-8):557-62. PubMed ID: 8920809
[TBL] [Abstract][Full Text] [Related]
7. Correlation between susceptibility and BRO type enzyme of Moraxella catarrhalis strains.
Kadry AA; Fouda SI; Elkhizzi NA; Shibl AM
Int J Antimicrob Agents; 2003 Nov; 22(5):532-6. PubMed ID: 14602374
[TBL] [Abstract][Full Text] [Related]
8. Plasmid-mediated beta-lactamase in Branhamella catarrhalis.
Kamme C; Eliasson I; Knutson BK; Vang M
Drugs; 1986; 31 Suppl 3():55-63. PubMed ID: 3488198
[TBL] [Abstract][Full Text] [Related]
9. Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.
McGregor K; Chang BJ; Mee BJ; Riley TV
Eur J Clin Microbiol Infect Dis; 1998 Apr; 17(4):219-34. PubMed ID: 9707304
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterization of the BRO beta-lactamase of Moraxella (Branhamella) catarrhalis.
Bootsma HJ; van Dijk H; Verhoef J; Fleer A; Mooi FR
Antimicrob Agents Chemother; 1996 Apr; 40(4):966-72. PubMed ID: 8849261
[TBL] [Abstract][Full Text] [Related]
11. beta-Lactam resistance and beta-lactamase isoforms of Moraxella catarrhalis isolates in Taiwan.
Fung CP; Lee SC; Liu PY; Jang TN; Wong FD; Kuo BI; Liu CY; Liu YC
J Formos Med Assoc; 1998 Jul; 97(7):453-7. PubMed ID: 9700241
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of restriction endonuclease analysis of BRO beta-lactamases in clinical and carrier isolates of Moraxella catarrhalis.
Köseoglu O; Ergin A; Hascelik G
Scand J Infect Dis; 2004; 36(6-7):431-4. PubMed ID: 15307563
[TBL] [Abstract][Full Text] [Related]
13. Rapid discrimination between BRO beta-lactamases from clinical isolates of Moraxella catarrhalis using restriction endonuclease analysis.
du Plessis M
Diagn Microbiol Infect Dis; 2001 Jan; 39(1):65-7. PubMed ID: 11173194
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Moraxella catarrhalis isolates to beta-lactam antibiotics in relation to beta-lactamase pattern.
Fung CP; Yeo SF; Livermore DM
J Antimicrob Chemother; 1994 Feb; 33(2):215-22. PubMed ID: 8182002
[TBL] [Abstract][Full Text] [Related]
15. [Molecular characterization of BRO beta-lactamases of Moraxella catarrhalis strains isolated from carrier children].
Köseoğlu O; Ergin A; Gürkan Aydin N; Hasçelik G
Mikrobiyol Bul; 2004 Oct; 38(4):335-40. PubMed ID: 15700658
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility and beta-lactamase characterization of Branhamella catarrhalis isolates from 1983/1984 and 1988.
Christensen JJ; Keiding J; Bruun B
APMIS; 1990 Nov; 98(11):1039-44. PubMed ID: 2123390
[TBL] [Abstract][Full Text] [Related]
17. Genesis of BRO beta-lactamase-producing Moraxella catarrhalis: evidence for transformation-mediated horizontal transfer.
Bootsma HJ; van Dijk H; Vauterin P; Verhoef J; Mooi FR
Mol Microbiol; 2000 Apr; 36(1):93-104. PubMed ID: 10760166
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of susceptibility patterns and BRO beta-lactamase types among clinical isolates of Moraxella catarrhalis.
Esel D; Ay-Altintop Y; Yagmur G; Gokahmetoglu S; Sumerkan B
Clin Microbiol Infect; 2007 Oct; 13(10):1023-5. PubMed ID: 17608812
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of the beta-lactamases from clinical isolates of Moraxella (Branhamella) catarrhalis obtained from 24 U.S. medical centers during 1994-1995 and 1997-1998.
Richter SS; Winokur PL; Brueggemann AB; Huynh HK; Rhomberg PR; Wingert EM; Doern GV
Antimicrob Agents Chemother; 2000 Feb; 44(2):444-6. PubMed ID: 10639381
[TBL] [Abstract][Full Text] [Related]
20. The frequency of BRO β-lactamase and its relationship to antimicrobial susceptibility and serum resistance in Moraxella catarrhalis.
Saito R; Nonaka S; Fujinami Y; Matsuoka S; Nakajima S; Nishiyama H; Okamura N
J Infect Chemother; 2014 Jan; 20(1):6-8. PubMed ID: 24462416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
